Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC644172 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC4A4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRMT61A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MYO5A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
LARP6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TARP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PREB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MTHFD2L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TCFL5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LBP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TPSAB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
INSIG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OGFRL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NECAB3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CFAP44 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRP2BP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PDE3B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRFN3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on